First long-acting injectable antiretroviral therapy for HIV recommended for approval

View source ↗

Summary

The EMA recommends approval of the first long-acting injectable antiretroviral therapy for HIV, representing a new treatment option with less frequent dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• long-acting injectable antiretroviral therapy